Anti-GD2 ADC M3554 in Advanced Solid Tumors

计划入组 52 人 · 首次发布于 2024 年 10 月 15 日

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

计划入组 138 人 · 首次发布于 2026 年 1 月 22 日

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

计划入组 138 人 · 首次发布于 2025 年 12 月 31 日

anti-HER2 ADC (Pfizer)

Anti-CD123 monoclonal antibody CPI conjugate (Pfizer)

ADC Therapeutics

Switzerland

ADC Therapeutics America, Inc.

United States

Novel Anti-Infective Technologies, LLC

UCSF Researchers Advance Novel Anti-Wnt2 Antibody-Drug Conjugate for Lung Cancer Treatment

Alphamab Oncology Presents Promising Phase I/II Data for Subcutaneous Anti-HER2 Bispecific ADC JSKN033

Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer Trial